Determinants of hepatic effector CD8+ T cell dynamics

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Laurent Mailly, Mirjam B. Zeisel, Thomas F. Baumert 
Volume 63, Issue 1, Pages (July 2015)
Volume 46, Issue 3, Pages (March 2007)
Evangelos Cholongitas, George V. Papatheodoridis, Andrew K. Burroughs 
Inflammasomes in liver diseases
Volume 58, Issue 1, Pages (January 2013)
Volume 50, Issue 4, Pages (April 2009)
Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: Perspectives and challenges  Marie-Louise Michel, Qiang Deng,
Volume 65, Issue 4, Pages (October 2016)
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
Tiny RNA with great effects: miR-155 in alcoholic liver disease
Volume 59, Issue 6, Pages (December 2013)
Hepatic CD141+IFNλ+ DC subset: One against all?
Mice With Human Livers Gastroenterology
Volume 44, Issue 2, Pages (February 2006)
Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar 
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
The function of serotonin within the liver
Immigration and viral hepatitis
Ype P. de Jong, Charles M. Rice, Alexander Ploss  Journal of Hepatology 
Stephanos J. Hadziyannis  Journal of Hepatology 
Living donor liver transplantation: is the hype over?
Nicolas Moniaux, Jamila Faivre  Journal of Hepatology 
Volume 69, Issue 2, Pages (August 2018)
Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection  Anaïs Vallet-Pichard,
Volume 44, Issue 4, Pages (April 2006)
Evangelos Cholongitas, George V. Papatheodoridis, Andrew K. Burroughs 
Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw  Journal of Hepatology 
Volume 68, Issue 1, Pages (January 2018)
Hepatitis C core protein – The “core” of immune deception?
Volume 142, Issue 7, Pages e3 (June 2012)
Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: Perspectives and challenges  Marie-Louise Michel, Qiang Deng,
Burcin Ekser, Eric Lagasse  Journal of Hepatology 
Marc van der Valk, Hans L. Zaaijer, Arnon P. Kater, Janke Schinkel 
Stimulation of hepatocarcinogenesis by neutrophils upon induction of oncogenic kras expression in transgenic zebrafish  Chuan Yan, Xiaojing Huo, Shu Wang,
Aloysious D. Aravinthan, Graeme J.M. Alexander  Journal of Hepatology 
Volume 44, Issue 2, Pages (February 2006)
Volume 61, Issue 1, Pages S69-S78 (November 2014)
Volume 45, Issue 4, Pages (October 2006)
Volume 62, Issue 3, Pages (March 2015)
Genomic risk of hepatitis C-related hepatocellular carcinoma
Autophagy in the liver Journal of Hepatology
Volume 65, Issue 4, Pages (October 2016)
Volume 59, Issue 3, Pages (September 2013)
Stephen Locarnini, Angelos Hatzakis, Ding-Shinn Chen, Anna Lok 
Quantitation of anti-HBe antibodies in anti-HBc-positive liver donors
HCMV jogs the ‘memory’ of NK cells in HBV
Volume 50, Issue 4, Pages (April 2009)
Non-invasive diagnosis and biomarkers in alcohol-related liver disease
Arjan Boltjes, Dowty Movita, André Boonstra, Andrea M. Woltman 
Liver stem cells—prospects for clinical use
Volume 56, Issue 6, Pages (June 2012)
Volume 44, Issue 2, Pages (February 2006)
Immigration and viral hepatitis
The potential of induced pluripotent stem cell derived hepatocytes
Volume 63, Issue 1, Pages (July 2015)
Volume 51, Issue 2, Pages (August 2009)
HCV animal models and liver disease
Statins: Old drugs as new therapy for liver diseases?
Pathogenesis of cholestatic hepatitis C
Chimeric mouse model of hepatitis B virus infection
Eric Robinet, Thomas F. Baumert  Journal of Hepatology 
Genetics of hepatocellular carcinoma: The next generation
Mirjam B. Zeisel, Marine Turek, Thomas F. Baumert 
Volume 64, Issue 3, Pages (March 2016)
Volume 64, Issue 6, Pages (June 2016)
Volume 53, Issue 4, Pages (October 2010)
Woo-Yong Lee, Paul Kubes  Journal of Hepatology 
Presentation transcript:

Determinants of hepatic effector CD8+ T cell dynamics Alexandre Pierre Benechet, Matteo Iannacone  Journal of Hepatology  Volume 66, Issue 1, Pages 228-233 (January 2017) DOI: 10.1016/j.jhep.2016.07.011 Copyright © 2016 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Liver immunohistochemical micrographs from representative mice that transgenically express HBcAg, all HBV gene products or that have been infected with Ad-HBV-GFP. Top, HBcAg in brown; middle, HBcAg in red; bottom, HBcAg in red and GFP in green. Note that fluorescent hepatocytes expressing HBcAg are also observed after infection with AAV-HBc-GFP (not shown). Percentages of hepatocytes expressing HBV antigens are indicated. Journal of Hepatology 2017 66, 228-233DOI: (10.1016/j.jhep.2016.07.011) Copyright © 2016 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Schematic representation of hepatic effector CD8+ T cell behavior leading to hepatocellular antigen recognition. (1) Effector CD8+ T cells arrest within liver sinusoids by docking onto platelets. (2) They crawl along liver sinusoids, probing hepatocytes for the presence of antigen by extending cellular protrusions through sinusoidal fenestrae. (3) They perform effector function in a diapedesis-independent manner (i.e., while still confined to the intravascular space). Journal of Hepatology 2017 66, 228-233DOI: (10.1016/j.jhep.2016.07.011) Copyright © 2016 European Association for the Study of the Liver Terms and Conditions

Fig. 3 Cell tracks in an intravital multiphoton microscopy movie in the liver of a hepatitis B virus (HBV) replication-competent transgenic mouse. Transferred with antigen-specific (green) or antigen non-specific (red) T cells. Scale bars represent 50μm. Journal of Hepatology 2017 66, 228-233DOI: (10.1016/j.jhep.2016.07.011) Copyright © 2016 European Association for the Study of the Liver Terms and Conditions